Predictive ADME-Tox

Expert Opinion on Drug Metabolism and Toxicology

Volumn 1, Issue 3, 2005, Pages 565-570

  Fostel, Jennifer ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

ADME; adverse drug reactions; in silico; in vitro; toxicity

Indexed keywords

DRUG;

BIOTRANSFORMATION; COMPUTER SIMULATION; CONFERENCE PAPER; DRUG DESIGN; METABOLISM; PHARMACOKINETICS; PHARMACOLOGY; TISSUE DISTRIBUTION; TOXICOGENETICS;

BIOTRANSFORMATION; COMPUTER SIMULATION; DRUG DESIGN; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; PHARMACOLOGY; TISSUE DISTRIBUTION; TOXICOGENETICS;

EID: 32444445534     PISSN: 17425255     EISSN: 17447607     Source Type: Journal    
DOI: 10.1517/17425255.1.3.565     Document Type: Conference Paper

References (24)

1. VAN DE WATERBEEMD H, GIFFORD E: ADMET in silico modelling: towards prediction paradise? Nat. Rev. Drug Discov. (2003) 2(3):192-204. (Pubitemid 37361664)
2. MARTIGNONI M, DE KANTER R, GROSSI P, MAHNKE A, SATURNO G, MONSHOUWER M: An in vivo and in vitro comparison of CYP induction in rat liver and intestine using slices and quantitative RT-PCR. Chem. Biol. Interact. (2004) 151(1):1-11. (Pubitemid 39647932)
3. RILEY RJ, KENNA JG: Cellular models for ADMET predictions and evaluation of drug-drug interactions. Curr. Opin. Drug Discov. Devel. (2004) 7(1):86-99. (Pubitemid 44111917)
4. SCHOONEN WG, WESTERINK WM, DE ROOS JA, DEBITON E: Cytotoxic effects of 100 reference compounds on Hep G2 and HeLa cells and of 60 compounds on ECC-1 and CHO cells. I mechanistic assays on ROS, glutathione depletion and calcein uptake. Toxicol. In Vitro (2005) 19(4):505-516.
5. SCHOONEN WG, DE ROOS JA, WESTERINK WM, DEBITON E: Cytotoxic effects of 110 reference compounds on HepG2 cells and for 60 compounds on HeLa, ECC-1 and CHO cells. II mechanistic assays on NAD(P)H, ATP and DNA contents. Toxicol. In Vitro (2005) 19(4):491-503.
6. BERRY J, PRICE-JONES M: Measurement of radioligand binding by scintillation proximity assay. Methods Mol. Biol. (2005) 306:121-137.
7. LINDON JC, NICHOLSON JK, HOLMES E, et al.: Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project. Toxicol. Appl. Pharmacol. (2003) 187(3):137-146. (Pubitemid 36349345)
8. WATERS M, BOORMAN G, BUSHEL P, et al.: Systems toxicology and the chemical effects in biological systems (CEBS) knowledge base. EHP Toxicogenomics (2003) 111:15-28. (Pubitemid 36157427)
9. JOHNSON TN: Modelling approaches to dose estimation in children. Br. J. Clin. Pharmacol. (2005) 59(6):663-669. (Pubitemid 40835498)
10. GREENE N, JUDSON PN, LANGOWSKI JJ, MARCHANT CA: Knowledge-based expert systems for toxicity and metabolism prediction: DEREK, StAR and METEOR. SAR QSAR Environ. Res. (1999) 10(2-3):299-314.
11. MATTHEWS EJ, CONTRERA JF: A new highly specific method for predicting the carcinogenic potential of pharmaceuticals in rodents using enhanced MCASE QSAR-ES software. Regul. Toxicol. Pharmacol. (1998) 28(3):242-264. (Pubitemid 29096166)
12. GOMBAR VK, ENSLEIN K, BLAKE BW: Assessment of developmental toxicity potential of chemicals by quantitative structure-toxicity relationship models. Chemosphere (1995) 31:2499-2510. (Pubitemid 26438479)
13. FLUCKIGER-ISLER S, BAUMEISTER M, BRAUN K, et al.: Assessment of the performance of the Ames II assay: a collaborative study with 19 coded compounds. Mutat. Res. (2004) 558:181-197. (Pubitemid 38229646)
14. VEBER DF, JOHNSON SR, CHENG HY, SMITH BR, WARD KW, KOPPLE KD: Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem. (2002) 45:2615-2623. (Pubitemid 34595232)
15. LU JJ, CRIMIN K, GOODWIN JT, et al.: Influence of molecular flexibility and polar surface area metrics on oral bioavailability in the rat. J. Med. Chem. (2004) 47:6104-6107. (Pubitemid 39507351)
16. REFSGAARD HH, JENSEN BF, BROCKHOFF PB, PADKJAER SB, GULDBRANDT M, CHRISTENSEN MS: In silico prediction of membrane permeability from calculated molecular parameters. J. Med. Chem. (2005) 48:805-811. (Pubitemid 40209102)
17. ZAMORA I, AFZELIUS L, CRUCIANI G: Predicting drug metabolism: a site of metabolism prediction tool applied to the cytochrome P450 2C9. J. Med. Chem. (2003) 46:2313-2324. (Pubitemid 36637916)
18. BOYER S, ZAMORA I: New methods in predictive metabolism. Mol. Divers. (2002) 5:277-287.
19. METT H, HOLSCHER K, DEGEN H et al.: Identification of inhibitors for a virally encoded protein kinase by 2 different screening systems: in vitro kinase assay and in-cell activity assay. J. Biomol. Screen. (2005) 10:36-45.
20. LIPINSKI CA, LOMBARDO F, DOMINY BW, FEENEY PJ: Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. (2001) 46(1-3):3-26. (Pubitemid 33653411)
21. http://www.ilsina.org/index.cfm?pubentityid=57
22. http://www.lhasalimited.org/index.php
23. https://www.thermo.com/com/cda/product/detail/1,1055,12903,00.html Vitotox website
24. http://www.gentronix.co.uk/product.html GreenScreen website